Intravenous Shiga toxin 2 promotes enteritis and renal injury characterized by polymorphonuclear leukocyte infiltration and thrombosis in Dutch Belted rabbits

Microbes and Infection

Volumn 10, Issue 6, 2008, Pages 650-656

  García, Alexis ^a   Marini, Robert P ^a   Catalfamo, James L ^b   Knox, Kimberly A ^a   Schauer, David B ^a   Rogers, Arlin B ^a   Fox, James G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Animal Health Diagnostic Center   (United States)

Author keywords

Dutch Belted rabbit; Hemolytic uremic syndrome; Shiga toxin

Indexed keywords

CYTOKINE; FIBRINOGEN; FIBRINOLYTIC FACTOR; INTERLEUKIN 8; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VEROTOXIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DIARRHEA; ENTERITIS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; KIDNEY INJURY; LIMULUS LYSATE TEST; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; THROMBOSIS;

ANIMALS; ENTERITIS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HEMOLYTIC-UREMIC SYNDROME; KIDNEY; NEUTROPHILS; RABBITS; SHIGA TOXIN 2; THROMBOSIS;

ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS;

EID: 44449120695     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.03.004     Document Type: Article

References (32)

1. Karmali M.A. Infection by Shiga toxin-producing Escherichia coli: an overview. Mol. Biotechnol. 26 (2004) 117-122
2. Proulx F., Seidman E.G., and Karpman D. Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr. Res. 50 (2001) 163-171
3. Boyd B., and Lingwood C. Verotoxin receptor glycolipid in human renal tissue. Nephron 51 (1989) 207-210
4. van de Kar N.C., Monnens L.A., Karmali M.A., and van Hinsbergh V.W. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80 (1992) 2755-2764
5. Chandler W.L., Jelacic S., Boster D.R., Ciol M.A., Williams G.D., Watkins S.L., Igarashi T., and Tarr P.I. Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N. Engl. J. Med. 346 (2002) 23-32
6. Fitzpatrick M.M., Shah V., Trompeter R.S., Dillon M.J., and Barratt T.M. Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int. 42 (1992) 951-956
7. Inward C.D., Howie A.J., Fitzpatrick M.M., Rafaat F., Milford D.V., Taylor C.M., and on behalf of the Association for Paediatric Nephrology. Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. Pediatr. Nephrol. 11 (1997) 556-559
8. van Setten P.A., van Hinsbergh V.W., van den Heuvel L.P., Preyers F., Dijkman H.B., Assmann K.J., van der Velden T.J., and Monnens L.A. Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patients with hemolytic uremic syndrome. Pediatr. Res. 43 (1998) 759-767
9. García A., Marini R.P., Feng Y., Vitsky A., Knox K.A., Taylor N.S., Schauer D.B., and Fox J.G. A naturally occurring rabbit model of enterohemorrhagic Escherichia coli-induced disease. J. Infect. Dis. 186 (2002) 1682-1686
10. García A., Bosques C.J., Wishnok J.S., Feng Y., Karalius B.J., Butterton J.R., Schauer D.B., Rogers A.B., and Fox J.G. Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli. J. Infect. Dis. 193 (2006) 1125-1134
11. Tsuji K., Steindler K.A., and Harrison S.J. Limulus amoebocyte lysate assay for detection and quantitation of endotoxin in a small-volume parenteral product. Appl. Environ. Microbiol. 40 (1980) 533-538
12. García A., and Fox J.G. The rabbit as a new reservoir host of enterohemorrhagic Escherichia coli. Emerg. Infect. Dis. 9 (2003) 1592-1597
13. Barrett T.J., Potter M.E., and Wachsmuth I.K. Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases. J. Infect. Dis. 159 (1989) 774-777
14. Fujii J., Kinoshita Y., Yutsudo T., Taniguchi H., Obrig T., and Yoshida S.I. Toxicity of Shiga toxin 1 in the central nervous system of rabbits. Infect. Immun. 69 (2001) 6545-6548
15. Mizuguchi M., Sugatani J., Maeda T., Momoi T., Arima K., Takashima S., Takeda T., and Miwa M. Cerebrovascular damage in young rabbits after intravenous administration of Shiga toxin 2. Acta Neuropathol. 102 (2001) 306-312
16. Newman D.J., Henneberry H., and Price C.P. Particle enhanced light scattering immunoassay. Ann. Clin. Biochem. 29 1 (1992) 22-42
17. Barrett T.J., Potter M.E., and Wachsmuth I.K. Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect. Immun. 57 (1989) 3434-3437
18. Zoja C., Angioletti S., Donadelli R., Zanchi C., Tomasoni S., Binda E., Imberti B., te Loo M., Monnens L., Remuzzi G., and Morigi M. Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int. 62 (2002) 846-856
19. Thorpe C.M., Hurley B.P., Lincicome L.L., Jacewicz M.S., Keusch G.T., and Acheson D.W. Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect. Immun. 67 (1999) 5985-5993
20. Elliott E., Li Z., Bell C., Stiel D., Buret A., Wallace J., Brzuszczak I., and O'Loughlin E. Modulation of host response to Escherichia coli O157:H7 infection by anti-CD18 antibody in rabbits. Gastroenterology 106 (1994) 1554-1561
21. Fernandez G.C., Lopez M.F., Gomez S.A., Ramos M.V., Bentancor L.V., Fernandez-Brando R.J., Landoni V.I., Dran G.I., Meiss R., Isturiz M.A., and Palermo M.S. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin. Exp. Immunol. 146 (2006) 76-84
22. Keepers T.R., Psotka M.A., Gross L.K., and Obrig T.G. A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J. Am. Soc. Nephrol. 17 (2006) 3404-3414
23. Roche J.K., Keepers T.R., Gross L.K., Seaner R.M., and Obrig T.G. CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation. Am. J. Pathol. 170 (2007) 526-537
24. Todd R., Donoff B.R., Chiang T., Chou M.Y., Elovic A., Gallagher G.T., and Wong D.T. The eosinophil as a cellular source of transforming growth factor alpha in healing cutaneous wounds. Am. J. Pathol. 138 (1991) 1307-1313
25. Esmon C.T. The interactions between inflammation and coagulation. Br. J. Haematol. 131 (2005) 417-430
26. Stahl A.L., Svensson M., Morgelin M., Svanborg C., Tarr P.I., Mooney J.C., Watkins S.L., Johnson R., and Karpman D. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 108 (2006) 167-176
27. Grabowski E.F., Nestoridi E., García A., Fox J.G., and Ingelfinger J.R. Tissue factor-driven enhanced platelet aggregation in flowing blood in a rabbit model of childhood hemolytic uremic syndrome. Blood (ASH Annual Meeting Abstracts) 106 (2005) 2166
28. Marshall L.J., Ramdin L.S.P., Brooks T., Charlton P., and Shute J.K. Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes. J. Immunol. 171 (2003) 2057-2065
29. Xu Y., Hagege J., Mougenot B., Sraer J.D., Ronne E., and Rondeau E. Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int. 50 (1996) 2011-2019
30. Raife T., Friedman K.D., and Fenwick B. Lepirudin prevents lethal effects of Shiga toxin in a canine model. Thromb. Haemost 92 (2004) 387-393
31. Siegler R.L., Pysher T.J., Tesh V.L., and Taylor Jr. F.B. Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome. J. Am. Soc. Nephrol. 12 (2001) 1458-1467
32. Bertani T., Abbate M., Zoja C., Corna D., and Remuzzi G. Sequence of glomerular changes in experimental endotoxemia: a possible model of hemolytic uremic syndrome. Nephron. 53 (1989) 330-337